CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06947304
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:26.779396+00:00
Published At: 2026-02-11T00:00:00+00:00
Record Updated At: 2026-02-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Nonalcoholic Steatohepatitis (NASH)", "Metabolic Dysfunction-Associated Steatohepatitis (MASH)", "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)", "Non-alcoholic Fatty Liver Disease (NAFLD)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-02-11"
protocolSection.identificationModule.nctId: "NCT06947304"
protocolSection.identificationModule.officialTitle: "A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.